Psilocybin Alpha Understands That MagicMed Will Be Acquired by Nasdaq-listed Enveric Biosciences Calgary-based MagicMed, which is “focused on assembling a portfolio of intellectual property” relating to psychedelic derivatives, is set to be acquired by Nasdaq-listed Enveric Biosciences by way of an amalgamation transaction. This news comes nearly six months after MagicMed closed its last (and … Continue reading MagicMed to Be Acquired by Nasdaq-Listed Company